Professor of Cardiology and Population Health Science and Policy, Mount Sinai Endowed Professor in Cardiovascular Clinical Research and Outcomes;
Director of Interventional Cardiovascular Research and Clinical Trials;
Director of Women’s Heart and Vascular Center at Mount Sinai Heart
Icahn School of Medicine at Mount Sinai, New York
New York, New York, United States
Dr. Roxana Mehran is an internationally renowned interventional cardiologist and clinical research expert in the field of cardiovascular disease. With over 1,600 peer-reviewed articles and a position on the ACC Board of Trustees, her influence is profound. For a decade. She is listed as Clarivate Analytics Most Cited Researchers – Top 1%, and Thomson Reuters list of The World’s Most Influential Scientific Minds.
As a principal investigator for numerous global studies and a key member of clinical guidelines committees, Dr. Mehran's expertise is widely recognized. She founded the Cardiovascular Research Foundation (CRF) and leads the Lancet Women and CVD Commission, addressing research gaps in women's cardiovascular health. Additionally, she established Women as One to empower women in medicine. On March 14th, 2024 she is honored with the prestigious Jacobi Medal from Icahn School of Medicine at Mount Sinai.
Disclosure(s): Abbott, Alleviant Medical, Chiesi, Concept Medical, Cordis, CPC Clinical Research, Daiichi Sankyo, Duke, Faraday Pharmaceuticals, Idorsia Pharmaceuticals, Janssen, MedAlliance, Medtronic, NewAmsterdam Pharma, Novartis, Novo Nordisk Inc.: Consulting Fees (e.g., advisory boards) (Ongoing), Grant/Research Support (Ongoing); AMA - JAMA Cardiology (Associate Editor), ACC (Vice President, BOT Member, SC Member CTR Program): Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); Elixir Medical, Stel, ControlRad (spouse): Stock Options [in privately held companies] (Ongoing); Population Health Research Institute (PHRI), Protembis GmbH, Radcliffe, RM Global Bioaccess Fund Management, Sanofi US Services, Inc. ;: Consulting Fees (e.g., advisory boards) (Ongoing), Grant/Research Support (Ongoing); SCAI (Women in Innovations Committee Member), Faculty Cardiovascular Research Foundation (CRF), Women as One (Founding Director): No Fees (Ongoing)
CRT 2026 Faculty Agreement to Participate
Saturday, March 7, 2026
8:00 AM - 8:00 PM EST